ArticlePhysiological research2026
The Injection of miR-1/133 Antagonist Notably Accelerated the Healing Process of Exercise-Induced Skeletal Muscle Injury.
Article in Physiological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exercise-induced muscle damage (EIMD) significantly impacts daily work and life. The rapid promotion of repair for EIMD is worthy of attention. This study aimed to investigate the effect and mechanism of microRNAs in treating EIMD. By establishing an acute skeletal muscle injury model, we determined the key time point for skeletal muscle injury repair and the time-specific changes in MRTF-A/Pax7/SRF and muscle regeneration factors during the repair process. MicroRNAs antagonists were injected to verify the targeting relationship between miR-1/133a and MRTF-A/Pax7/SRF. A single bout of acute eccentric exercise caused significant damage to the morphological ultrastructure of rat gastrocnemius muscles, with the most severe injuries occurring 72 h after exercise. At this particular time point, it was identified as crucial for damage repair. Both miR-1-3p and miR-133a-3p collectively targeted and suppressed the protein translation of MRTF-A, Pax7, and SRF. Furthermore, both miR-1-3p and miR-133a-3p antagonists targeted the MRTF-A/Pax7 axis as well as the MRTF-A/SRF axis. MiR-1-3p antagonists primarily promote muscle proliferation and differentiation, while miR-133a-3p antagonists mainly promote differentiation while inhibiting atrophy. Combined injection effectively promote both muscle proliferation and differentiation while inhibiting atrophy, thereby facilitating damage repair in skeletal muscle fiber structure. Key words Exercise " Muscle damage " Skeletal muscle regeneration " MRTF-A " Pax7 " SRF.
Indexed as
Identifiers
42484080PMC13557540What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.